Jiangsu Hengrui Pharmaceuticals Co.,Ltd
600276Pharmaceuticals
CN¥48.62+0.54%As of Oct 29vs prior close
- Market cap
- $46.6B
- P/E (TTM)
- 36.0×
- P/E (FY1)
- 35.5×
- From 52W high
- −24.34%
- EPS (LTM)
- CN¥1.16
- Revenue (LTM)
- CN¥32.6B
- Net margin
- 27.04%
- Dividend yield
- 0.41%
Nomior Score
28
Steady ProfileBottom 13% of the scored universe
Growth47
Quality58
Value24
Momentum2
Resilience60
Growth
+14.13%revenue a year over 3 fiscal years
YE22 CN¥21.3BLTM CN¥32.6B
Connections
Revenue to profitYE25
24% of revenue became net profit, up 2 pts on a year.